XML 63 R48.htm IDEA: XBRL DOCUMENT v3.23.3
SCHEDULE OF CASH AND CASH EQUIVALENTS AND INVESTMENTS (Details) - USD ($)
12 Months Ended
Jun. 30, 2022
Jun. 30, 2023
Impairment Effects on Earnings Per Share [Line Items]    
Cash and Cash Equivalents $ 16,249,666 $ 5,619,083
Cash [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Cost 1,233,608 242,271
Cash and Cash Equivalents 1,233,608 242,271
Money Market Funds [Member] | Fair Value, Inputs, Level 1 [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Cost 15,016,058 5,376,812
Cash and Cash Equivalents 15,016,058 5,376,812
Fair Value 15,016,058 5,376,812
Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 1 [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Cost 16,249,666 5,619,083
Cash and Cash Equivalents 16,249,666 5,619,083
Fair Value 15,016,058 $ 5,376,812
Investments [Member] | Fair Value, Inputs, Level 1 [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Cost 245,187  
Fair Value 239,314  
Unrealized Gain (Loss) (5,873)  
Investments $ 239,314